Lipocine LPCN
NASDAQ LPCN
$2.05 -0.02 (-0.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lipocine (LPCN) Selling, General & Administrative (2011 - 2025)

Updated

Lipocine (LPCN) posted Selling, General & Administrative of $767,837 for Q3 2025, down 26.5% from $1.05 million a year earlier and down 13.8% from the prior quarter.

Analysis

Lipocine (LPCN) Selling, General & Administrative (2011 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, Selling, General & Administrative at Lipocine was $3.65 million, down 30.6% year-over-year; for FY2024, it came in at $5 million, up 2.0% from FY2023.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of -2.2% (FY2019 to FY2024).
  • In prior years, Lipocine's Selling, General & Administrative was $4.9 million in FY2023 (+20.7%), $4.06 million in FY2022 (-23.8%), $5.33 million in FY2021 (-35.4%) and $8.25 million in FY2020 (+47.4%).
  • The Q3 2025 figure stands as the lowest quarterly Selling, General & Administrative since Q2 2013.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last four quarters, with an average decline of 8.1% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2020, with growth of 44.4%; the weakest was Q4 2021, with a decline of 54.9%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $890,433 (Q2 2025), $1.12 million (Q1 2025) and $873,055 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Lipocine 11.11 Mn -56.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 767,837.00
Jun 30, 2025 890,433.00
Mar 31, 2025 1.12 Mn
Dec 31, 2024 873,055.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 1.51 Mn
Mar 31, 2024 1.58 Mn
Dec 31, 2023 1.13 Mn
Sep 30, 2023 1.04 Mn
Jun 30, 2023 1.44 Mn
Mar 31, 2023 1.29 Mn
Dec 31, 2022 890,343.00
Sep 30, 2022 798,939.00
Jun 30, 2022 1.13 Mn
Mar 31, 2022 1.24 Mn
Dec 31, 2021 1.05 Mn
Sep 30, 2021 1.22 Mn
Jun 30, 2021 1.53 Mn
Mar 31, 2021 1.53 Mn
Dec 31, 2020 2.32 Mn
API Access

Lipocine Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LPCN&period=max&api_key=YOUR_API_KEY